1. Home
  2. RNXT vs MAMK Comparison

RNXT vs MAMK Comparison

Compare RNXT & MAMK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • MAMK
  • Stock Information
  • Founded
  • RNXT 2012
  • MAMK 2007
  • Country
  • RNXT United States
  • MAMK China
  • Employees
  • RNXT N/A
  • MAMK N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • MAMK Apparel
  • Sector
  • RNXT Health Care
  • MAMK Consumer Discretionary
  • Exchange
  • RNXT Nasdaq
  • MAMK Nasdaq
  • Market Cap
  • RNXT 44.6M
  • MAMK 43.2M
  • IPO Year
  • RNXT 2021
  • MAMK 2025
  • Fundamental
  • Price
  • RNXT $1.26
  • MAMK $2.31
  • Analyst Decision
  • RNXT Strong Buy
  • MAMK
  • Analyst Count
  • RNXT 2
  • MAMK 0
  • Target Price
  • RNXT $7.50
  • MAMK N/A
  • AVG Volume (30 Days)
  • RNXT 648.4K
  • MAMK 75.3K
  • Earning Date
  • RNXT 11-12-2025
  • MAMK 01-01-0001
  • Dividend Yield
  • RNXT N/A
  • MAMK N/A
  • EPS Growth
  • RNXT N/A
  • MAMK N/A
  • EPS
  • RNXT N/A
  • MAMK 0.12
  • Revenue
  • RNXT $662,000.00
  • MAMK $21,434,100.00
  • Revenue This Year
  • RNXT $2,895.35
  • MAMK N/A
  • Revenue Next Year
  • RNXT $313.04
  • MAMK N/A
  • P/E Ratio
  • RNXT N/A
  • MAMK $21.26
  • Revenue Growth
  • RNXT N/A
  • MAMK N/A
  • 52 Week Low
  • RNXT $0.75
  • MAMK $1.87
  • 52 Week High
  • RNXT $1.69
  • MAMK $4.00
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 58.65
  • MAMK N/A
  • Support Level
  • RNXT $1.19
  • MAMK N/A
  • Resistance Level
  • RNXT $1.45
  • MAMK N/A
  • Average True Range (ATR)
  • RNXT 0.12
  • MAMK 0.00
  • MACD
  • RNXT 0.02
  • MAMK 0.00
  • Stochastic Oscillator
  • RNXT 62.75
  • MAMK 0.00

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About MAMK MaxsMaking Inc. Class A Ordinary Shares

MaxsMaking Inc is a manufacturer of consumer goods with a focus on technology and innovation. It is serving small and medium-sized enterprises and individual e-commerce sellers with their needs for small batch products, It currently use cotton cloth, nylon cloth, polyester, recycled polyethylene terephthalate (rPET) and other materials to produce backpacks, shopping bags, aprons, tablecloths and other consumer goods. It serve enterprises, schools, government agencies, non-profit organizations, e-commerce sellers and various groups and organizations to meet their needs for small-batch products.

Share on Social Networks: